Clinical Investigator
Justin Lindemann
AstraZeneca
Total Trials
1
As PI
0
Completed
1
h-index
N/A
Publications
0
Years Active
0
Research Impact
h-index
N/A
Research impact score
Publications
0
Total publications
Trial Results
0
Published trial results
Citations
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Phase 11
Trial Status
Completed1
Role Distribution
Other Roles1
Activity Timeline
Clinical Trials (1)
AZD9496 First Time in Patients Ascending Dose Study
ER+ HER2- Advanced Breast Cancer
StudydirectorStart date: 2014-10-22
Research Network
Collaboration Network
2 collaborators·1 connections
Network Legend
KOL
Current InvestigatorCO
High-influence CollaboratorCO
CollaboratorClick: view details
Double-click: go to profile
Drag: move node
Research Areas & Affiliations
Therapeutic Areas
Affiliations
AstraZeneca
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
5 similar investigators found
Richard Baird, MD PhD FRCP
Breast Cancer Research Unit, University of Cambridge
1 trials
Shared therapeutic areas:
ER+ HER2- Advanced Breast Cancer
Worked with same sponsors:
AstraZeneca
Similarity Score30%
Richard Baird, MD, PhD
Cambridge University Hospitals
1 trials
Shared therapeutic areas:
ER+ HER2- Advanced Breast Cancer
Worked with same sponsors:
AstraZeneca
Similarity Score30%
Martine Piccart, Md, PhD
Jules Bordet Institute
3 trials
Shared therapeutic areas:
ER+ HER2- Advanced Breast Cancer
Similarity Score30%
Justin Lindemann, MBChB MBA
AstraZeneca
2 trials
Shared therapeutic areas:
ER+ HER2- Advanced Breast Cancer
Worked with same sponsors:
AstraZeneca
Similarity Score30%
Erika Hamilton
Nashville Hospital, United States
1 trials
Shared therapeutic areas:
ER+ HER2- Advanced Breast Cancer
Worked with same sponsors:
AstraZeneca
Collaborated on 1 trial
Similarity Score14%
Publications (0)
No publications found for this investigator.
Clinical Trials (1)
Showing 1 of 1 trials
AZD9496 First Time in Patients Ascending Dose Study
ER+ HER2- Advanced Breast Cancer
All 1 trials loaded